Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran
- PMID: 29807408
- PMCID: PMC6060339
- DOI: 10.4178/epih.e2018020
Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran
Abstract
Objectives: Hypertension (HTN) is an important risk factor for cardiovascular disease. Considering the importance of this disease for public health, this study was designed in order to determine the prevalence, awareness, treatment, control, and risk factors of HTN in the Iranian adult population.
Methods: This cross-sectional study was conducted among 2,107 residents of Isfahan, Iran. Samples were selected through multi-stage random cluster sampling in 2015-2016. The outcome variable was HTN, determined by measuring blood pressure in the right arm via a digital arm blood pressure monitor. Awareness, treatment, and control of HTN were assessed by a validated and reliable researcher-developed questionnaire. Other demographic and clinical variables were assessed via a demographic questionnaire.
Results: The overall prevalence of HTN was 17.3% (18.9 and 15.5% in men and women, respectively). The prevalence of HTN increased in both genders with age. The prevalence of awareness of HTN among people with HTN was 69.2%, of whom 92.4 and 59.9% were taking medication for HTN and had controlled HTN, respectively. Logistic regression identified age, body mass index, having diabetes and hyperlipidemia, and a positive family history of HTN as determinants of awareness of HTN.
Conclusions: The results showed that HTN was highly prevalent in the community, especially in men and in middle-aged and older adults. Approximately 30.8% of patients were unaware of their disease, and there was less awareness among younger adults. Despite the high frequency of taking medication to treat HTN, it was uncontrolled in more than 40.1% of patients. Health policy-makers should therefore consider appropriate preventive and therapeutic strategies for these high-risk groups.
Keywords: Blood pressure; Chronic diseases; Epidemiology; Hypertension; Iran; Risk factors.
Conflict of interest statement
The authors have no conflicts of interest to declare for this study.
Figures
References
-
- Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics-- 2013 update: a report from the American Heart Association. Circulation. 2013;127:143–152. - PubMed
-
- Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260. - PMC - PubMed
-
- Mostafavi A, Sekhavatfar P, Tabatabaei SA, Khavandi S, Rasoulighasemlouei S. Prevalence of cardiac risk factors in ischemic stroke in a university medical center in Tehran. Iran Heart J. 2016;17:57–63.
-
- Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci. 2012;25:251–256. - PubMed
-
- World Health Organization A global brief on hypertension: silent killer, global public health crisis. 2013 [cited 2018 Jun 4]. Available from: http://www.who.int/cardiovascular_diseases/publications/global_brief_hyp...
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
